Thematics Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$29.3M Buy
60,484
+8,647
+17% +$4.02M 1.33% 18
2025
Q2
$21M Buy
51,837
+1,038
+2% +$434K 0.95% 41
2025
Q1
$25.3M Buy
50,799
+6,963
+16% +$3.77M 1.28% 24
2024
Q4
$22.8M Sell
43,836
-9,983
-19% -$5.49M 1% 34
2024
Q3
$33.3M Sell
53,819
-842
-2% -$498K 1.32% 19
2024
Q2
$30.2M Hold
54,661
1.23% 19
2024
Q1
$31.8M Sell
54,661
-1,000
-2% -$561K 1.32% 18
2023
Q4
$29.5M Sell
55,661
-735
-1% -$356K 1.3% 18
2023
Q3
$28.5M Sell
56,396
-21,414
-28% -$11.4M 1.4% 12
2023
Q2
$40.6M Buy
77,810
+1,700
+2% +$917K 1.95% 8
2023
Q1
$43.9M Sell
76,110
-10,619
-12% -$5.99M 2.39% 1
2022
Q4
$47.8M Buy
+86,729
New +$46M 2.9% 1

Other funds holding TMO

Thematics Asset Management's TMO Position: Q3 2025 in Review

Thematics Asset Management increased its Thermo Fisher Scientific (TMO) stake by 17% in Q3 2025, buying an estimated $4.02M and bringing the position to 60,484 shares worth $29.3M. The position accounts for 1.33% of the portfolio, ranked #18.

Thematics Asset Management first reported a position in TMO in Q4 2022 and has held it in 12 quarters since. The position peaked at $47.8M in Q4 2022. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Thematics Asset Management held 60,484 shares of Thermo Fisher Scientific worth $29.3M as of Q3 2025.
  • Thematics Asset Management bought 8,647 Thermo Fisher Scientific shares in Q3 2025, an estimated $4.02M.
  • Thermo Fisher Scientific made up 1.33% of Thematics Asset Management's portfolio in Q3 2025, its #18 holding.
  • Thematics Asset Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 12 quarters since.
  • Thematics Asset Management's Thermo Fisher Scientific position peaked at $47.8M in Q4 2022.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Thematics Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.